Immunovant, Inc. (IMVT)
NASDAQ: IMVT · Real-Time Price · USD
21.27
+0.82 (4.01%)
At close: Feb 21, 2025, 4:00 PM
21.35
+0.08 (0.38%)
After-hours: Feb 21, 2025, 7:49 PM EST
Immunovant Analyst Ratings
Total Analysts
12
Consensus Rating
Strong Buy
Price Target
$45.90
Upside
+115.80%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Strong Buy Maintains $46 → $44 | Strong Buy | Maintains | $46 → $44 | +106.86% | Feb 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $51 | Strong Buy | Reiterates | $51 | +139.77% | Feb 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $51 | Strong Buy | Reiterates | $51 | +139.77% | Feb 7, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $48 → $45 | Strong Buy | Maintains | $48 → $45 | +111.57% | Jan 15, 2025 |
| Wolfe Research | Wolfe Research | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Jan 3, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $47 → $45 | Buy | Maintains | $47 → $45 | +111.57% | Dec 19, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $51 | Strong Buy | Reiterates | $51 | +139.77% | Nov 8, 2024 |
| Raymond James | Raymond James | Buy Initiates $36 | Buy | Initiates | $36 | +69.25% | Oct 10, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $47 → $53 | Buy | Maintains | $47 → $53 | +149.18% | Oct 9, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $51 | Strong Buy | Reiterates | $51 | +139.77% | Sep 30, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $51 | Strong Buy | Reiterates | $51 | +139.77% | Sep 10, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Sep 9, 2024 |
| UBS | UBS | Strong Buy Maintains $42 → $41 | Strong Buy | Maintains | $42 → $41 | +92.76% | Aug 13, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $51 → $46 | Buy | Maintains | $51 → $46 | +116.27% | Aug 8, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Aug 7, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Jun 20, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.